Munich - Delayed Quote EUR

Tvardi Therapeutics Inc. R (69C.MU)

16.88
+0.74
+(4.56%)
At close: April 24 at 8:23:53 AM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
Operating Expense
21,969
18,665
21,193
Operating Income
-21,969
-18,665
-21,193
Net Non Operating Interest Income Expense
928
1,318
651
Pretax Income
-21,041
-17,347
-20,542
Net Income Common Stockholders
-21,041
-17,347
-20,542
Diluted NI Available to Com Stockholders
-21,041
-17,347
-20,542
Basic EPS
-2.25
-1.85
-2.20
Diluted EPS
-2.25
-1.85
-2.20
Basic Average Shares
9,355.54
9,355.54
9,355.54
Diluted Average Shares
9,355.54
9,355.54
9,355.54
Total Operating Income as Reported
-21,969
-18,665
-21,193
Total Expenses
21,969
18,665
21,193
Net Income from Continuing & Discontinued Operation
-21,041
-17,347
-20,542
Normalized Income
-21,041
-17,347
-20,542
Interest Income
928
1,318
654
Interest Expense
--
--
3
Net Interest Income
928
1,318
651
EBIT
-20,651
-17,347
-20,539
EBITDA
-20,556
-17,252
-20,454
Reconciled Depreciation
95
95
85
Net Income from Continuing Operation Net Minority Interest
-21,041
-17,347
-20,542
Normalized EBITDA
-20,556
-17,252
-20,454
12/31/2022 - 4/16/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SCP.F Scancell Holdings plc
0.1060
+4.95%
 
6XP.SG Xspray Pharma AB (publ)
3.4000
+4.29%
 
1T3.F Syndax Pharmaceuticals, Inc.
11.20
0.00%
 
7UM0.F Zelluna ASA
1.2760
-2.60%
 
0M4.F Mersana Therapeutics, Inc.
0.2879
-1.61%
 
GBM.F Inovio Pharmaceuticals, Inc.
1.6200
0.00%
 
5CV.DE CureVac N.V.
2.8580
+0.42%
 
GNTA Genenta Science S.p.A.
3.9200
+2.62%
 
ELDN Eledon Pharmaceuticals, Inc.
3.3600
0.00%
 
TRVI Trevi Therapeutics, Inc.
6.35
+1.28%